Prof Tsiknakis: Launch of the federal European infrastructure for cancer imaging

Published on: October 23, 2023
Categories: News

The EUCAIM (European Federation for Cancer Images) project is the cornerstone of the European Cancer Imaging Initiative, launched by the European Commission, within the framework of the European Beating Cancer Plan, emphasized Prof. Manolis Tsiknakis, as Coordinator of the ProCAncer-I project and Affiliated Professor at the Computational Biomedicine Laboratory (CBML), speaking at the Health IT conference. As he mentioned, the project is based on the results of the “AI for Health Imaging (AI4HI)” initiative and the projects funded by it, among which is the ProCΑncer-I project (https://www.procancer-i.eu) – a project coordinated by the Foundation for Research and Technology.

It is the first of its kind European “pan-cancer” project that aims to give easy access to cancer images to clinicians, doctors and researchers with the aim of developing artificial intelligence (AI) tools that will support more accurate and faster clinical decision-making, diagnoses, and determining the most appropriate treatment for cancer patients. EUCAIM will address the data fragmentation that exists in existing cancer imaging medical image repositories and develop a distributed Atlas of Cancer Imaging with more than 60 million anonymized cancer imaging data from more than 100,000 patients, accessible to clinicians, physicians, and researchers across the EU to develop and evaluate reliable AI tools.

The 6th Health IT Conference in Athens, on the 17th and 18th of October, focusing on Digital Transformation in the era of EHDS.

Read more

 

The EUCAIM (European Federation for Cancer Images) project is the cornerstone of the European Cancer Imaging Initiative, launched by the European Commission, within the framework of the European Beating Cancer Plan, emphasized Prof. Manolis Tsiknakis, as Coordinator of the ProCAncer-I project and Affiliated Professor at the Computational Biomedicine Laboratory (CBML), speaking at the Health IT conference. As he mentioned, the project is based on the results of the “AI for Health Imaging (AI4HI)” initiative and the projects funded by it, among which is the ProCΑncer-I project (https://www.procancer-i.eu) – a project coordinated by the Foundation for Research and Technology.

It is the first of its kind European “pan-cancer” project that aims to give easy access to cancer images to clinicians, doctors and researchers with the aim of developing artificial intelligence (AI) tools that will support more accurate and faster clinical decision-making, diagnoses, and determining the most appropriate treatment for cancer patients. EUCAIM will address the data fragmentation that exists in existing cancer imaging medical image repositories and develop a distributed Atlas of Cancer Imaging with more than 60 million anonymized cancer imaging data from more than 100,000 patients, accessible to clinicians, physicians, and researchers across the EU to develop and evaluate reliable AI tools.

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Stay in touch!